title: Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrhage: a report of two case stories.
abstract: BACKGROUND
  Diffuse alveolar haemorrhage (DAH) is a serious pulmonary complication characterised by a high mortality rate and the absence of specific treatment. The intrapulmonary administration of activated recombinant factor VII (rFVIIa) in DAH was recently published in six patients by Heslet et al with an efficient hemostatic effect. We describe two cases of DAH treated with intrapulmonary rFVIIa.
  
  
  METHODS
  Two cases of DAH were admitted to the ICU after presenting abrupt desaturation, tachypnea, cough and haemoptysis, requiring orotracheal intubation and mechanical ventilation. The diagnosis was achieved by the bloody return during the bronchoalveolar lavage, during the procedure rFVIIa (50 mug/Kg in 50 ml of isotonic saline) was administered via the bronchoscope.
  
  
  RESULTS
  Immediate cessation of bleeding was observed. Prior to intrapulmonary administration of rFVIIa, the FiO2 was 1, which was reduced to 0.4 24 hours later. Following the procedure, the haemostatic effect made blood transfusion superfluous. No thrombotic complications associated with administration of the drug were observed. After the intervention both cases progressed fast and was discharged from the ICU with no further episodes of bleeding.
  
  
  CONCLUSIONS
  1. Local intrabronchial deposition of DAH with rFVIIa has been shown to be effective in controlling life-threatening DAH. 2. In the case described above, no thrombotic complications were observed following the intrapulmonary administration of rFVIIa.
authors.affiliation: Critical Care Unit, Hospital of Jerez, Spain. litoestella@hotmail.com.
authors.forename: Angel
authors.initials: A
authors.lastname: Estella
authors.forename: Antonio
authors.initials: A
authors.lastname: Jareño
authors.forename: Luis
authors.initials: L
authors.lastname: Perez-Bello Fontaiña
references.citation: Crit Care. 2006;10(6):R177
references.pmid: 17184515
references.citation: Clin Exp Rheumatol. 2006 Mar-Apr;24(2 Suppl 41):S48-59
references.pmid: 16859597
references.citation: Bone Marrow Transplant. 2000 Sep;26(5):539-43
references.pmid: 11019844
references.citation: Am J Med. 1989 Nov;87(5):511-8
references.pmid: 2816966
references.citation: Heart. 2004 Mar;90(3):e15
references.pmid: 14966076
references.citation: Chest. 2006 Aug;130(2):577-9
references.pmid: 16899862
references.citation: AJR Am J Roentgenol. 1991 Sep;157(3):461-4
references.pmid: 1872226
references.citation: J Thromb Haemost. 2005 Sep;3(9):1935-44
references.pmid: 16102099
references.citation: J Invasive Cardiol. 2001 Jul;13(7):535-7
references.pmid: 11435642
references.citation: Chest. 1996 Mar;109(3):727-9
references.pmid: 8617083
references.citation: Bone Marrow Transplant. 2000 May;25(9):975-9
references.pmid: 10800066
references.citation: Med Intensiva. 2007 Aug-Sep;31(6):326-30
references.pmid: 17663958
references.citation: Chest. 2000 Nov;118(5):1431-5
references.pmid: 11083697